IGC Pharma (IGC) FCF Margin (QoQ) (2010 - 2025)
IGC Pharma (IGC) FCF Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - |
| 10 | IGC Pharma | 29.05 Mn | 28.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -67,802.00 |
| Jun 30, 2025 | -20,474.00 |
| Mar 31, 2025 | 29,629.00 |
| Dec 31, 2024 | -27,417.00 |
| Sep 30, 2024 | 40,930.00 |
| Jun 30, 2024 | -47,470.00 |
| Mar 31, 2024 | 62,788.00 |
| Dec 31, 2023 | -24,323.00 |
| Sep 30, 2023 | -29,993.00 |
| Jun 30, 2023 | 64,876.00 |
| Mar 31, 2023 | -24,518.00 |
| Dec 31, 2022 | -3,703.00 |
| Sep 30, 2022 | 46,110.00 |
| Jun 30, 2022 | -17,034.00 |
| Mar 31, 2022 | 76,051.00 |
| Dec 31, 2021 | 229,801.00 |
| Sep 30, 2021 | -145,925.00 |
| Jun 30, 2021 | 238,273.00 |
| Mar 31, 2021 | -319,907.00 |
| Dec 31, 2020 | 26,127.00 |